These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15954931)

  • 1. Can murine diabetic nephropathy be separated from superimposed acute renal failure?
    Tay YC; Wang Y; Kairaitis L; Rangan GK; Zhang C; Harris DC
    Kidney Int; 2005 Jul; 68(1):391-8. PubMed ID: 15954931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice.
    Kamli-Salino SEJ; Brown PAJ; Haschler TN; Liang L; Feliers D; Wilson HM; Delibegovic M
    Biochem Biophys Res Commun; 2023 Apr; 650():109-116. PubMed ID: 36774688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.
    Zent R; Yan X; Su Y; Hudson BG; Borza DB; Moeckel GW; Qi Z; Sado Y; Breyer MD; Voziyan P; Pozzi A
    Kidney Int; 2006 Aug; 70(3):460-70. PubMed ID: 16775606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
    Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
    Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.
    Uil M; Scantlebery AML; Butter LM; Larsen PWB; de Boer OJ; Leemans JC; Florquin S; Roelofs JJTH
    Sci Rep; 2018 Apr; 8(1):5542. PubMed ID: 29615804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model.
    Palm F; Ortsäter H; Hansell P; Liss P; Carlsson PO
    Diabetes Metab Res Rev; 2004; 20(6):452-9. PubMed ID: 15386825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes.
    Hartner A; Cordasic N; Klanke B; Wittmann M; Veelken R; Hilgers KF
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F820-7. PubMed ID: 17018847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Rodionov RN; Jarzebska N; Schneider A; Rexin A; Sradnick J; Brilloff S; Martens-Lobenhoffer J; Bode-Böger SM; Todorov V; Hugo C; Weiss N; Hohenstein B
    Atheroscler Suppl; 2019 Dec; 40():100-105. PubMed ID: 31818438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
    Tian L; Nikolic-Paterson DJ; Tesch GH
    Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem attenuates oxidative stress in diabetic rats.
    Anjaneyulu M; Chopra K
    Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
    Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
    J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
    Jialal I; Major AM; Devaraj S
    J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.
    Wada J; Zhang H; Tsuchiyama Y; Hiragushi K; Hida K; Shikata K; Kanwar YS; Makino H
    Kidney Int; 2001 Apr; 59(4):1363-73. PubMed ID: 11260397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.
    He L; Hao L; Fu X; Huang M; Li R
    BMC Nephrol; 2015 Apr; 16():51. PubMed ID: 25884847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.